Medpedia

cafepharma 1099 Independent Pharmaceutical Sales Representative US: Tris Pharma, Inc. is a rapidly growing, tec... http://t.co/FLNTLWsk February 3rd 01:10PM

cafepharma Abbott, Hospira Win Appellate Affirmation in Spinoff Retirement Lawsuit: Bloomberg Fri, 02/03/12 - 12:36 pm http://t.co/ftq4pwXk February 3rd 10:32AM

cafepharma FDA talks, but doctors don't necessarily listen: Fierce Pharma Fri, 02/03/12 - 11:57 am http://t.co/Oa8VFioe February 3rd 09:27AM

cafepharma Idenix Falls Casualty to Gilead Hep C Hoopla: http://t.co/Vzc9mdpa Fri, 02/03/12 - 11:56 am http://t.co/Ir1eoyA9 February 3rd 09:27AM

cafepharma FDA talks, but doctors don't necessarily listen: Fierce Pharma Fri, 02/03/12 - 11:57 am http://t.co/Oa8VFioe February 3rd 09:27AM

cafepharma Questcor posts strong Q4 revenue, shares up: Reuters Fri, 02/03/12 - 11:55 am http://t.co/ZXz9KXXz February 3rd 09:27AM

cafepharma Pharma Grows In Importance To India's Nifty Fifty: Seeking Alpha Fri, 02/03/12 - 11:52 am http://t.co/0BBZppN5 February 3rd 09:27AM

PharmaNews Merck KGaA Signs $550 Million Cancer Pact With Threshold Pharmaceuticals, Inc. http://t.co/7wqm9IiX February 3rd 08:39AM

PharmaNews Gilead Sciences, Inc. Soars on Positive Data From Experimental Hepatitis C Drug; Stock Rises +4.78(9.69%) @ 10:08AM EST http://t.co/Ou0uCZrA February 3rd 08:39AM

PharmaNews FDA OKs Merck & Co., Inc.'s Janumet XR for Type 2 Diabetes http://t.co/TD5U8x1o February 3rd 08:39AM

PharmaNews Q&A About $100 Million Asia, Emerging Markets Strategy With AstraZeneca PLC's Head of R&D http://t.co/oKgpeuhQ February 3rd 08:39AM

PharmaNews Idenix Pharmaceuticals, Inc. Receives FDA Notification That Partial Clinical Hold on IDX184 Removed http://t.co/J66N83ND February 3rd 08:39AM

cafepharma Amgen risk/reward attractive into Xgeva panel, says Deutsche Bank: Yahoo/Fly on the Wall Fri, 02/03/12 - 10:00 am http://t.co/lzjIAlE9 February 3rd 07:50AM

cafepharma AstraZeneca Declines Most in 5 Months on Forecast: London Mover: Bloomberg Fri, 02/03/12 - 9:58 am http://t.co/eej0wt8H February 3rd 07:50AM

cafepharma Don't Get Too Worked Up Over BioMarin Pharmaceutical's Earnings: Motley Fool Fri, 02/03/12 - 9:55 am http://t.co/7prhQBxT February 3rd 07:50AM

cafepharma Neurocrine Biosciences Still Worth Watching: Seeking Alpha Fri, 02/03/12 - 9:51 am http://t.co/43E917hq February 3rd 07:50AM

cafepharma 2 Biotech Stocks Leading This Rally: Seeking Alpha Fri, 02/03/12 - 9:49 am http://t.co/6ZJuwiuH February 3rd 07:50AM

eMPR Janumet XR Approved for Type 2 #Diabetes http://t.co/9Rvu4vKC #endocrinology February 3rd 07:22AM

cafepharma J&J Hid Risperdal Studies to Boost Drug Sales, Lawyer Says: Bloomberg Businessweek Fri, 02/03/12 - 9:48 am http://t.co/cXeOOm50 February 3rd 07:17AM

cafepharma Merck wins approval for extended release Janumet: Boston Globe, MA Fri, 02/03/12 - 9:48 am http://t.co/0iHNTSN8 February 3rd 07:17AM

cafepharma Gilead Sciences 4Q profit rises on HIV drug sales: Yahoo/AP Fri, 02/03/12 - 9:47 am http://t.co/jrdEMlSh February 3rd 07:17AM

cafepharma Vertex Pharma reports 4th-quarter profit as sales of hepatitis C drug Incivek reach $456.8M: Yahoo/AP Fri, 02/03/12... http://t.co/GaNEw2HL February 3rd 07:17AM

cafepharma Dr. Reddy’s Q3 FY12 Financial Results: Highest Ever Quarterly Sales and Profit: Yahoo Fri, 02/03/12 - 9:45 am http://t.co/5zCijQgE February 3rd 07:17AM

TomLamb McGill asbestos study flawed, epidemiologist says (2/2/12, CBC News) re: Canada selling asbestos to developing world http://t.co/Enl1T0sg February 3rd 05:11AM

cafepharma General Surgeon/Independent Business Owner US: As a physician in this community, I know how difficul... http://t.co/7Hhx79Ar February 2nd 01:15PM